Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Stents at 25 years: A revolution in revascularization
• Salt reduction and stroke: A special need for a special population Wallace Johnson, MD
• ACTIVE I: Irbesartan failed to lower CV events in patients with AF
• Antihypertensive treatment improved outcomes in non-hypertensive patients with CVD
• APOLLO: Efficacy of ADRC therapy documented in STEMI patients
• Clopidogrel, dipyridamole yield similar embolyzation reduction in patients taking aspirin
• DOSE: Diuretic dosage, IV delivery approach did not affect symptoms of patients with acute decompensated HF
• EARLY ACS: Routine vs. delayed provisional use of eptifibatide may improve patient outcomes
• Imaging modality may detect abnormal resting coronary blood flow
• Intracardiac system allows real-time image guidance, heart visualization
• Mandatory ECG screening in Israel failed to lower sudden death, cardiac arrest risk
• One-minute CPR training video improved attempt rate, skill of nonprofessionals
• PARTNER: Promising initial results countered by need for patience
• PRECISE: Adipose-derived stem cells show utility as therapy
• Rates, risk factors for CV events associated with Fabry’s disease
• Recovery expectations for patients with CAD reflect long-term survival
• Registry data identified risk factors linked with complications after ICD replacement
• Researchers document post-transplantation mortality rates in adults with congenital heart disease
• Researchers identify, describe structure of HDL
• Short-, long-term stroke risks present major obstacle for carotid stenting
• Stroke and death rates similar in stenosis patients undergoing stenting or endarterectomy
• Updated guidelines for CVD prevention in women encompass clinical practice findings
• CONNECT: Wireless remote monitoring ICDs, CRT-Ds significantly lowered length of hospital stay
• Sex-specific data available before approval of high-risk CV devices lacking
• TRPM4 causes autosomal dominant isolated cardiac conduction disease Robert Roberts, MD, FRSC, FRCPC, MACC, LLD (Hon.), FAHA; Calvin W. Roberts, MD; William L. Roberts, MHA, CPA; Brandon A. Roberts, MSc, MD
• CVD medication usage of older patients heavily influenced by adverse effects
• Epicardial, endocardial ablation feasible option for monomorphic VT in HCM patients
• Referral strategy led to high rate of cardiac rehabilitation use
• Resource use increased among Medicare beneficiaries with HF at end of life
• David P. Faxon, MD, cardiologist with a committed passion for helping others
• FUTURA/OASIS 8: Post-PCI bleeding rates comparable in patients given low, high dose of unfractionated heparin
• One-year outcomes similar between paclitaxel-, everolimus-eluting stents
• Registry data highlight importance of clinical conditions in treating CTO lesions
• Biologics and biosimilars: Are they? Aparna Yerramilli, PharmD